Join us for the 7th Annual MI4 Scientific Symposium 鈥� 鈥淪olutions to Antimicrobial Resistance鈥�
Date: Wednesday, November 19, 2025
Time: 11:30 AM 鈥� 5:30 PM
Location: 黑料网爆吃瓜 (details to follow upon registration)
Registration deadline: Wednesday, November 12, 2025
Antimicrobial resistance (AMR) represents one of the most urgent health challenges of our time, and MI4鈥檚 7th Annual Scientific Symposium will bring together leading minds to explore actionable solutions. This one-day event will showcase groundbreaking research, interdisciplinary collaboration, and forward-looking strategies to combat the rise of resistant pathogens.
Don鈥檛 miss the opportunity to connect with global and local experts driving innovation in this field.
Keynote Address
Professor Stewart Cole
Executive Chair, Ineos Oxford Institute
An internationally renowned microbiologist, Professor Stewart Cole is celebrated for his pioneering work on the genomics and pathogenicity of mycobacteria that cause tuberculosis (TB) and leprosy. His research has accelerated TB drug and vaccine development, leading to candidate drugs now in clinical trials. Formerly President of the Institut Pasteur in Paris, Professor Cole currently leads the Ineos Oxford Institute for Antimicrobial Research, continuing his mission to translate discovery into real-world health solutions.
Featured Local Experts
Professor Karine Auclair
Canada Research Chair in Antimicrobials and Green Enzymes
A trailblazer in bioorganic chemistry, Professor Auclair has made landmark contributions to antibiotic resistance research and to the emerging field of mechanoenzymology. With more than 100 peer-reviewed publications, several patents, and global recognition, her work continues to inspire new approaches to sustainable biochemistry and therapeutic innovation.
Dr. Martin Schmeing
Director, Centre de recherche en biologie structurale
Dr. Schmeing鈥檚 research delves into the molecular architecture of nonribosomal peptide synthetases (NRPSs), large microbial enzymes responsible for producing many of the world鈥檚 most powerful natural therapeutics. His work reveals how these biological 鈥渁ssembly lines鈥� create compounds with antibiotic, antiviral, and anticancer properties 鈥� insights that could transform future drug discovery.
Dr. Sara Mahshid
Canada Research Chair in Nano-Biosensing Devices
At the intersection of nanotechnology, bioengineering, and AI, Dr. Mahshid develops cutting-edge nano-biosensing diagnostic platforms. Her goal: to translate fundamental discoveries into bedside tools for detecting cancer and infectious diseases. Her leadership in international networks and her impressive track record of innovation position her as a rising force in translational diagnostics.
Dr. Yves Longtin
President, Association of Medical Microbiology and Infectious Disease (AMMI) Canada
An infectious diseases specialist at the Jewish General Hospital, Dr. Longtin leads national efforts to prevent and control multidrug-resistant infections. As Chair of Canada鈥檚 surveillance program on carbapenem-resistant organisms, he combines clinical insight with public health leadership to improve infection control and patient safety across the country.
Why Attend?
- Engage directly with experts advancing the science and solutions of antimicrobial resistance.
- Gain insights into emerging therapies, diagnostics, and global health strategies.
- Network with researchers, clinicians, and innovators shaping the future of infectious disease management.
Seats are limited 鈥� register by Wednesday, November 12, 2025 to secure your place at MI4鈥檚 premier annual research event.
听
